CTNM
Contineum Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Contineum Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Contineum Therapeutics, Inc.
9.39
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Suvretta Capital ManagementSuvretta | $46.6M | 9.30% | 0.00% | |
| 2 | Jupiter TopcoJupiter Topco | $44.8M | 8.94% | — | |
| 3 | BlackRockBlackRockindex-like | $33.8M | 6.76% | +208.52% | |
| 4 | Johnson & JohnsonJohnson & Johnson | $32.4M | 6.48% | 0.00% | |
| 5 | Franklin ResourcesFranklin Resources | $30.1M | 6.02% | 0.00% | |
| 6 | Balyasny Asset ManagementBalyasny | $25.0M | 4.98% | −9.66% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $21.7M | 4.32% | +8.83% | |
| 8 | Perceptive AdvisorsPerceptive | $20.6M | 4.11% | 0.00% | |
| 9 | FMRFMR | $17.0M | 3.40% | +27.64% | |
| 10 | Millennium ManagementMillennium | $15.3M | 3.05% | −39.32% | |
| 11 | Great Point PartnersGreat Point Partners | $15.1M | 3.02% | +15.16% | |
| 12 | Longaeva PartnersLongaeva Partners | $13.3M | 2.66% | +11.02% | |
| 13 | Ikarian CapitalIkarian Capital | $13.2M | 2.64% | 0.00% | |
| 14 | Sectoral Asset ManagementSectoral | $11.9M | 2.38% | 0.00% | |
| 15 | Geode Capital ManagementGeodeindex-like | $11.4M | 2.27% | +145.78% | |
| 16 | Hillhouse Capital AdvisorsHillhouse Capital | $11.0M | 2.19% | 0.00% | |
| 17 | Red Tree ManagementRed Tree | $10.5M | 2.09% | 0.00% | |
| 18 | Versant Venture ManagementVersant Venture | $8.9M | 1.78% | 0.00% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $8.2M | 1.63% | +61.92% | |
| 20 | Boxer Capital ManagementBoxer | $8.1M | 1.62% | 0.00% | |
| 21 | State StreetState Streetindex-like | $7.0M | 1.39% | +320.53% | |
| 22 | Citadel AdvisorsCitadel | $6.5M | 1.30% | +13.18% | |
| 23 | Adage Capital Partners GPAdage Capital Partners GP | $5.4M | 1.07% | new | |
| 24 | Silverarc Capital ManagementSilverarc | $4.9M | 0.97% | −1.85% | |
| 25 | ADAR1 Capital ManagementADAR1 | $4.6M | 0.91% | +0.83% |
102 managers report $500.8M of Contineum Therapeutics on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; Suvretta is largest at 9.30%.
Expected move
No implied move.
No implied move.
No implied move.